Central Laboratories Solutions
-
Transform Clinical Trials With Cognizant SIP: Efficient, Collaborative, Virtual
10/10/2022
Cognizant Shared Investigator Platform (SIP) provides a single point of access for multiple clinical trial resources across sponsors and investigation sites.
-
Site Cloud: End Of Study (EOS)
1/2/2023
Site Cloud: End of Study is the first end-to-end solution that seamlessly generates, distributes & manages sites’ study files at the end of a study. With EOS, sites’ study files are accessible and downloadable via a secure and trusted unified platform, eliminating the need to create and distribute physical media and deal with paper acknowledgment forms.
-
Transform Your Study On A Unified Platform
3/21/2023
The Medidata Clinical Cloud transforms the clinical trial experience for patients, sponsors, CROs and research sties. As the industry’s only unified platform dedicated to clinical research, the Medidata Clinical Cloud address the holistic research process from start to finish.
-
Balancing Compliance Among The Shifting Sands Of Pharmaceutical Data Privacy Regulations
8/26/2022
Maximize compliance, increase revenue potential, and improve patient safety by leveraging proven technology.
-
Revvity Signals Software Solutions For Pharmacovigilance And Drug Safety
5/13/2022
Strategically transform your medical review, safety review, and compliance monitoring processes with our innovative solution for Pharmacovigilance.
-
TA Scan CRM
1/27/2023
Manage the entire Medical Expert lifecycle with a suite of tools built around the everyday activities to drive success for your External Expert programs.
-
Glioblastoma Multiforme: Medidata AI’s Synthetic Control Arm
11/15/2022
Medidata AI’s Synthetic Control Arm® (SCA®) leverages historical clinical trial data (HCTD) to provide a more relevant clinical insight for the purpose of developing new therapies.
-
Transforming Medical Data Into Research Insights
10/19/2023
Discover the efficiency and security of automated, precise source data capture.
-
Drug Development Strategy & Analytics
7/27/2021
Read how IQVIA Biotech can help develop a strategy that will effectively translate into trial execution and avoid costly amendments down the road.
-
Driving Success In Dermatology Drug Development
Our dedicated teams are led by in-house, board-certified dermatologists who have decades of experience conducting early and late phase studies. Download the available brochure to learn more.